Ustekinumab a Strong Option for Moderate to Severe Psoriasis - Medscape

Ustekinumab a beardown Option for Moderate to Severe Psoriasis Medscape Ustekinumab has been approved for the treatment of average to severe psoriasis . The AAD included this drug in its attention guidelines, published in the February issue of the Journal of the North American country Academy of Dermatology, for the treatment of ... Link To Article